布洛芬是否增加儿童扁桃体切除术后出血风险?
该回顾性队列研究基于PHIS数据库,纳入2004至2015年551137例≤18岁扁桃体切除术±腺样体切除术患儿,评估术后出血(PTH)危险因素。使用布洛芬与PTH风险升高相关(aOR 1.36;95%CI 1.22,1.52),但鉴于其获益,是否改变实践尚不明确。
要点
- 儿童扁桃体切除术后出血率1.58%,2010至2015年显著上升。
- 布洛芬使用与PTH风险升高相关(aOR 1.36;95%CI 1.22,1.52)。
- 高龄、男性、合并症、复发性扁桃体炎及ICU入住亦为危险因素。
核心结论
- 儿童扁桃体切除术后出血发生率在2011至2015年间显著增加,布洛芬可能是 contributing factor 之一。
- 鉴于布洛芬的获益,目前尚不清楚该风险增加是否足以改变临床实践。
研究设计与样本
- 回顾性队列研究,使用Pediatric Health Information System(PHIS)数据库。
- 纳入2004至2015年≤18岁接受扁桃体切除术伴或不伴腺样体切除术(T±A)的患儿,共551137例。
主要发现
- 8735例(1.58%)发生术后出血(PTH)。
- 年龄≥12岁 vs <5岁(aOR 3.17;95%CI 2.86,3.52)、男性(aOR 1.11;95%CI 1.05,1.17)、合并症(aOR 1.18;95%CI 1.08,1.29)、复发性扁桃体炎(aOR 1.15;95%CI 1.07,1.24)、ICU入住(aOR 1.74;95%CI 1.55,1.95)与PTH风险增加相关。
- 使用布洛芬(aOR 1.36;95%CI 1.22,1.52)、酮咯酸(aOR 1.39;95%CI 1.14,1.69)、抗惊厥药(aOR 1.23;95%CI 1.03,1.76)、抗抑郁药(aOR 1.35;95%CI 1.03,1.76)与PTH风险增加相关。
- 需要输血的比例为2.1%(181/8735)。
临床怎么用
- 临床医生在为儿童扁桃体切除术后患儿处方布洛芬时,应权衡其镇痛获益与PTH风险增加。
- 对高龄、男性、有合并症、复发性扁桃体炎或ICU入住等高危患儿,需加强术后出血监测。
局限性
- 回顾性研究设计可能受混杂因素影响。
- 使用行政数据库,可能存在编码偏倚和未测量的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate risk factors for pediatric posttonsillectomy hemorrhage (PTH) and the need for transfusion using a national database. STUDY DESIGN: Retrospective cohort study. SETTING: The study was conducted using the Pediatric Health Information System (PHIS) database. METHODS: Children ≤18 years who underwent tonsillectomy with or without adenoidectomy (T±A) between 2004 and 2015 were included. We evaluated the risk of PTH requiring cauterization according to patient demographics, comorbidities, indication for surgery, medications, year of surgery, and geographic region. RESULTS: Of the 551,137 PHIS patients who underwent T±A, 8735 patients (1.58%) experienced a PTH. The risk of PTH increased from 1.33% (95% confidence interval [CI]: 1.15%, 1.53%) in 2010 to 1.91% (95% CI: 1.64%, 2.24%) in 2015 (P < .001). Older age (≥12 vs <5 years old: adjusted odds ratio [aOR] 3.17; 95% CI: 2.86, 3.52), male sex (aOR 1.11; 95% CI: 1.05, 1.17), medical comorbidities (aOR 1.18; 95% CI: 1.08, 1.29), recurrent tonsillitis (aOR 1.15; 95% CI: 1.07, 1.24), and intensive care unit admission (aOR 1.74; 95% CI: 1.55, 1.95) were significantly associated with an increased risk of PTH. Use of ibuprofen (aOR 1.36; 95% CI: 1.22, 1.52), ketorolac (aOR 1.39; 95% CI: 1.14, 1.69), anticonvulsant (aOR 1.23; 95% CI: 1.03, 1.76), and antidepressants (aOR 1.35; 95% CI: 1.03, 1.76) were also associated with an increased risk of PTH. The need for blood transfusion was 2.1% (181/8735). CONCLUSION: The incidence of PTH increased significantly between 2011 and 2015, and ibuprofen appears to be one contributing factor. Given the benefits of ibuprofen, it is unclear whether this increased risk warrants a change in practice.
引用
- Leung P, DeVore EK, Kawai K, et al. Does Ibuprofen Increase Bleed Risk for Pediatric Tonsillectomy? Otolaryngol Head Neck Surg. 2020. PMID: 33170769. doi:10.1177/0194599820970943
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。